Differential mRNA expression of seven genes involved in cholesterol metabolism and transport in the liver of atherosclerosis-susceptible and -resistant Japanese quail strains

Genetics Selection Evolution

Volumn 44, Issue 1, 2012, Pages

  Li, Xinrui ^a,b   Schulte, Patricia ^a   Godin, David V ^a   Cheng, Kimberly M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Novozymes (China) Investment Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIRD; DIET; EXCRETION; GENE EXPRESSION; LIPID; METABOLISM; MITOCHONDRIAL DNA;

COTURNIX; COTURNIX JAPONICA; PHASIANIDAE;

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MEVALONIC ACID; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; BLOOD; CLASSIFICATION; COTURNIX; DIET; DISEASE PREDISPOSITION; DISEASE RESISTANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LIVER; MALE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CHOLESTEROL; COTURNIX; DIET; DISEASE RESISTANCE; DISEASE SUSCEPTIBILITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIVER; MALE; MEVALONIC ACID; REAL-TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84861952010     PISSN: 0999193X     EISSN: 12979686     Source Type: Journal    
DOI: 10.1186/1297-9686-44-20     Document Type: Article

References (35)

1. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. Braunwald E, New Engl J Med 1997 337 1360 1369 10.1056/NEJM199711063371906 9358131
2. Atherosclerosis: the road ahead. Glass CK, Witztum JL, Cell 2001 104 503 516 10.1016/S0092-8674(01)00238-0 11239408
3. ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis. Jakulj L, Vissers MN, Tanck MWT, Hutten BA, Stellaard F, Kastelein JJP, Dallinga-Thie GM, J Lipid Res 2010 51 3016 3023 10.1194/jlr.M008128 20581104
4. Naturally-occurring atherosclerosis in birds. Clarkson TB, Middleton CC, Prichard RW, Lofland HB, Ann NY Acad Sci 1965 127 685 693 5217287
5. Genetic selection, general characterization, and histology of atherosclerosis-susceptible and -resistant Japanese quail. Shih JC, Pullman EP, Kao KJ, Atherosclerosis 1983 49 41 53 10.1016/0021-9150(83)90006-0 6651912
6. Antioxidant status of Japanese quail: comparison of atherosclerosis- susceptible and -resistant strains. Godin DV, Cheng KM, Garnett ME, Nichols CR, Can J Cardiol 1994 10 221 228 8143223
7. Sex-related alterations in antioxidant status and susceptibility to atherosclerosis in Japanese quail. Godin DV, Garnett ME, Cheng KM, Nichols CR, Can J Cardiol 1995 11 945 951 7489535
8. Alterations in aortic antioxidant components in an experimental model of atherosclerosis: a time-course study. Godin DV, Nichols CR, Hoekstra KA, Garnett ME, Cheng KM, Mol Cell Biochem 2003 252 193 203 10.1023/A:1025548111491 14577593
9. Dietary cholesterol absorption; more than just bile. Lu K, Lee MH, Patel SB, Trends Endocrinol Metab 2001 12 314 320 10.1016/S1043-2760(01)00433-7 11504671
10. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM, J Lipid Res 2000 41 1495 1508 10974057
11. Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM, Curr Opin Lipidol 2004 15 645 649 10.1097/00041433-200412000-00004 15529023
12. High-density lipoprotein function recent advances. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC, J Am Coll Cardiol 2005 46 1792 1798 10.1016/j.jacc.2005.06.080 16286161
13. Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Mori R, Wang Q, Danenberg KD, Pinski JK, Danenberg PV, Prostate 2008 68 1555 1560 10.1002/pros.20815 18651557
14. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. Warnick GR, Albers JJ, J Lipid Res 1978 19 65 76 202660
15. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Warnick GR, Nauck M, Rifa NI, Clin Chem 2001 47 1579 1596 11514391
16. Laboratory evaluation of a novel capillary blood sampling device for measuring eight clinical chemistry parameters and HbA1c. Gootjes J, Tel RM, Bergkamp FJ, Gorgels JP, Clin Chim Acta 2009 401 152 157 10.1016/j.cca.2008.12. 016 19138681
17. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382
18. Low-density lipoprotein cholesterol can be chemically measured: a new superior method. Okada M, Matsui H, Ito Y, Fujiwara A, Inano K, J Lab Clin Med 1998 132 195 201 10.1016/S0022-2143(98)90168-8 9735925
19. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH, Science 2000 290 1771 1775 11099417
20. High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr/ mice. Wilund KR, Yu L, Xu F, Hobbs HH, Cohen JC, J Lipid Res 2004 45 1429 1436 10.1194/jlr.M400167-JLR200 15175362
21. A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. Klett EL, Lu K, Kosters A, Vink E, Lee MH, Altenburg M, Shefer S, Batta AK, Yu H, Chen J, Klein R, Looije N, Oude-Elferink R, Groen AK, Maeda N, Salen G, Patel SB, BMC Med 2004 2 5 10.1186/1741-7015-2-5 15040800
22. Mutations in the human ATP-binding cassette transporters ABCG5 and ABCG8 in sitosterolemia. Heimerl S, Langmann T, Moehle C, Mauerer R, Dean M, Beil F-U, von Bergmann K, Schmitz G, Human Mutat 2002 20 151
23. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH, J Clin Invest 2002 110 671 680 12208868
24. Differential expression of hepatic genes involved in cholesterol homeostasis in high- and low-responding strains of laboratory opossums. Chan J, Donalson LM, Kushwaha RS, Ferdinandusse S, VandeBerg JF, VandeBerg JL, Metabolism 2008 57 718 724 10.1016/j.metabol.2008.01.018 18442639
25. SREBP-2 and NF-Y are involved in the transcriptional regulation of squalene epoxidase. Nagai M, Sakakibara J, Nakamura Y, Gejyo F, Ono T, Biochem Biophys Res Commun 2002 295 74 80 10.1016/S0006-291X(02)00623-X 12083769
26. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ, J Biol Chem 2002 277 18793 18800 10.1074/jbc.M109927200 11901146
27. Biological role of liver X receptors. Baranowski M, J Physiol Pharmacol 2008 59 31 55 19258656
28. ATP-Binding cassette cholesterol transporters and cardiovascular disease. Oram JF, Vaughan AM, Circ Res 2006 99 1031 1043 10.1161/01.RES.0000250171. 54048.5c 17095732
29. Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor. Plosch T, Bloks VW, Terasawa Y, Berdy S, Siegler K, Van Der Sluijs F, Kema IP, Groen AK, Shan B, Kuipers F, Schwarz M, Gastroenterology 2004 126 290 300 10.1053/j.gastro.2003.10.074 14699507
30. Regulation of the mevalonate pathway. Goldstein JL, Brown MS, Nature 1990 343 425 430 10.1038/343425a0 1967820
31. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. Brown MS, Goldstein JL, J Lipid Res 2009 50 15 S27 18974038
32. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Horton JD, Goldstein JL, Brown MS, J Clin Invest 2002 109 1125 1131 11994399
33. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo. Meigs TE, Roseman DS, Simoni RD, J Biol Chem 1996 271 7916 7922 10.1074/jbc.271.14.7916 8626470
34. Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase. Meigs TE, Simoni RD, Arch Biochem Biophys 1997 345 1 9 10.1006/abbi.1997.0200 9281305
35. Rapid transcriptome characterization for a nonmodel organism using 454 pyrosequencing. Vera JC, Wheat CW, Fescemyer HW, Frilander MJ, Crawford DL, Hanski I, Marden JH, Mol Ecol 2008 17 1636 1647 10.1111/j.1365-294X.2008.03666.x 18266620